Members |
targetComponentId |
Polymyxin b sulfate + trimethoprim sulfate |
Product containing polymyxin B and trimethoprim (medicinal product) |
Polyomavirus group |
Genus Polyomavirus (organism) |
Polyomavirus hominis |
Genus Polyomavirus (organism) |
polysomatöst missbildat foster |
Polysomia (disorder) |
polyvinylalkohol 1,4 %, ögondroppar |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
polyvinylalkohol 1,4 %, ögondroppar för engångsbruk |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
havsbraxen eller svartfisk, livsmedel |
Pomfret (substance) |
Poor concentration |
Poor concentration |
Poor concentration |
Poor concentration |
Poor concentration |
Poor concentration |
Poor labor contractions |
Uterine inertia |
långsam metaboliserare på grund av cytokrom P450, variant CYP2C19 |
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding) |
långsam metaboliserare på grund av cytokrom P450, variant CYP2C9 |
Cytochrome P450 family 2 subfamily C member 9 poor metabolizer (finding) |
långsam metaboliserare på grund av cytokrom P450, variant CYP2D6 |
Cytochrome P450 family 2 subfamily D member 6 poor metabolizer (finding) |
porcin faktor VIII, 700 IE, pulver och vätska till injektionsvätska, lösning, flaska |
Product containing only porcine factor VIII in parenteral dose form (medicinal product form) |
Porphyromonas assacharolytica |
Porphyromonas asaccharolyticus |
Porphyromonas endodontalis |
Porphyromonas endodontalis |
Porpoise distemper virus |
Cetacean morbillivirus (organism) |
Portable electroencephalogram awake and asleep with hyperventilation and/or photic stimulation |
Portable electroencephalogram awake and asleep with stimulation |
Portable electroencephalogram awake and drowsy with hyperventilation and/or photic stimulation |
Portable electroencephalogram awake and drowsy with stimulation |
manlig urinrörsmynnings läge |
Position of male external urethral orifice (observable entity) |
PET-undersökning av myokardiet i vila med ^81^Rb |
Positron emission tomography myocardial rest imaging using rubidium-82 (procedure) |
PET-undersökning av myokardiet under belastning med ^81^Rb |
Positron emission tomography myocardial stress imaging using rubidium-82 (procedure) |
PET-undersökning med datortomografi av myokardiet i vila med ^81^Rb |
Positron emission tomography with computed tomography myocardial rest imaging using rubidium-82 (procedure) |
PET-undersökning med datortomografi av myokardiet under belastning med ^81^Rb |
Positron emission tomography with computed tomography myocardial stress imaging using rubidium-82 (procedure) |
möjlig graviditet |
Possible pregnancy |
lymfoproliferativ sjukdom efter transplantation |
Post-transplantation lymphoproliferation (morphologic abnormality) |
posttranslationell genetisk RNA-modifiering |
Post-transcriptional genetic ribonucleic acid processing (finding) |
Postcoital bleeding |
Postcoital bleeding |
Posterior cervical cord injury without bony injury, C5-7 |
Posterior cervical spinal cord injury without spinal bone injury, C5-7 (disorder) |
Posterior cervical cord injury, without bony injury, C1-4 |
Posterior cervical spinal cord injury, without spinal bone injury, C1-4 (disorder) |
Posterior ligament of iris |
Trabecular meshwork structure |
postnatal anti-D-profylax avböjd |
Administration of RhD immune globulin declined |
postoperativ cellulit i operationssår |
Postoperative wound cellulitis |
postoperativa åtgärder |
Postoperative procedure (procedure) |
Postoperative pulmonary edema |
Postoperative pulmonary edema |
Posttraumatic wound infection, NEC |
Post-traumatic wound infection |
Postural proteinuria |
Orthostatic proteinuria (finding) |
kalium 6,5 millimol, brustablett |
Potassium only product in oral dose form |
kaliumallergi |
Propensity to adverse reaction to potassium (finding) |
kaliumvätekarbonat 1,39 g + citronsyra 1,14 g, löslig tablett |
Citric acid and potassium bicarbonate only product in oral dose form |
kaliumklorid 10 %, injektionsvätska, lösning, ampull |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumklorid 10 milliekvivalenter, tablett med modifierad frisättning |
Product containing only potassium chloride in oral dose form (medicinal product form) |
kaliumklorid 10 milliekvivalenter, depåtablett |
Product containing only potassium chloride in oral dose form (medicinal product form) |
dextros 4 % + kaliumklorid 10 mmol , infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
dextros 5 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
glukos 5 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
natriumklorid 0,9 % + kaliumklorid 10 mmol, infusionsvätska, lösning, påse 500 ml |
Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Potassium chloride 1500mg |
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
Potassium chloride 15meq |
Potassium chloride only product |
kaliumklorid 15 milliekvivalenter per förpackning |
Potassium chloride only product |
kaliumklorid 1 000 mg/5 ml, lösning |
Potassium chloride only product |
kaliumklorid 1 000 mg/ml, lösning |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumklorid 20 %, injektionsvätska, lösning, ampull |
Potassium chloride 200 mg/mL solution for injection |
kaliumklorid 20 %, lösning |
Potassium chloride only product |
kaliumklorid 20 milliekvivalenter, pulver |
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Potassium chloride 20meq/15m solution |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumklorid 20 milliekvivalenter/15 ml, lösning |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumklorid 20 milliekvivalenter per förpackning |
Potassium chloride only product |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
glukos 5 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
glukos 5 % + kaliumklorid 20 millimol, infusionsvätska, lösning, påse 500 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 1 000 ml |
Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
natriumklorid 0,9 % + kaliumklorid 20 mmol, infusionsvätska, lösning, påse 500 ml |
Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
glukos 5 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection |
natriumklorid 0,9 % + kaliumklorid 27 mmol, infusionsvätska, lösning, påse 1000 ml |
Product containing precisely potassium chloride 2 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
dextros 4 % + natriumklorid 0,18 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
glukos 5 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
natriumklorid 0,9 % + kaliumklorid 40 mmol, infusionsvätska, lösning, påse 1 000 ml |
Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumklorid 7,5 %, sirap |
Product containing only potassium chloride in oral dose form (medicinal product form) |
injektionskoncentrat kaliumklorid 15 %, lösning, ampull |
Product containing only potassium chloride in parenteral dose form (medicinal product form) |
kaliumcitrat 12 g/10 ml koncentrerad blandning |
Product containing only potassium citrate in oral dose form (medicinal product form) |
kaliumcitrat 12 g/10 ml, oral lösning |
Product containing only potassium citrate in oral dose form (medicinal product form) |
kaliumcitrat 3 g/dospåse, granulat |
Product containing only potassium citrate in oral dose form (medicinal product form) |
biverkningar av kaliumklorazepat |
Adverse reaction to clorazepate |
kaliumglukonat 20 milliekvivalenter/15 ml, elixir |
Product containing precisely potassium gluconate 312 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumpermanganat 400 mg, tablett till kutan lösning |
Product containing permanganic acid in cutaneous dose form (medicinal product form) |
kaliumpermanganat 400 mg, tablett till lösning |
Product containing permanganic acid in cutaneous dose form (medicinal product form) |
kaliumfosfat 2 mmol/ml, injektionsvätska, lösning, ampull 10 ml |
Product containing precisely monobasic potassium phosphate 136 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumtillskott |
Potassium and/or potassium compound |
potatis, livsmedel |
Potato (substance) |
Potexvirus group |
Genus Potexvirus (organism) |
Potts fraktur |
Bimalleolar fracture of ankle |
Pouched mammal |
Infraclass Metatheria (organism) |
povidon 5 %, ögondroppar |
Povidone 50 mg/mL eye solution |
povidon 5 %, ögondroppar för engångsbruk |
Povidone 50 mg/mL eye solution |
joderad povidon 10 %, preparat för pensling |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
joderad povidon 10 %, svamp för lokalt bruk |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
joderad povidon 10 %, vaginalgel |
Iodine (as povidone iodine) 100 mg/g vaginal gel |
joderad povidon 20 %, svamp för lokalt bruk |
Povidone iodine only product in cutaneous dose form |
joderad povidon 200 mg, suppositorium |
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
joderad povidon 5 %, svamp för lokalt bruk |
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
pulver till suspension |
Powder (basic dose form) |
Powered wheelchair |
Motorized wheelchair device (physical object) |
Poxvirus group |
Family Poxviridae (organism) |
Pramipexole dihydrochloride 125micrograms tablet |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug) |
Pramipexole dihydrochloride 1mg tablet |
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet |
Pramipexole dihydrochloride 250micrograms tablet |
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet |
pramlintid 1 mg/ml, injektionsvätska, lösning, förfylld penna |
Pramlintide only product |